Dawes Fretzin Clinical Research - Shadeland Ave. — Indianapolis, Indiana

Dawes Fretzin Clinical Research - Shadeland Ave. is a clinical research site located in Indianapolis, Indiana, United States 46250.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Dawes Fretzin Clinical Research - Shadeland Ave. has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Cutaneous Squamous Cell Carcinoma (CSCC).

Sponsors: Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dawes Fretzin Clinical Research - Shadeland Ave.?

Dawes Fretzin Clinical Research - Shadeland Ave. has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dawes Fretzin Clinical Research - Shadeland Ave. conducted?

Dawes Fretzin Clinical Research - Shadeland Ave. has 1 clinical trials on record, with 1 currently active. Their work covers Cutaneous Squamous Cell Carcinoma (CSCC).

Is Dawes Fretzin Clinical Research - Shadeland Ave. accredited by Crixeo Health?

Dawes Fretzin Clinical Research - Shadeland Ave. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dawes Fretzin Clinical Research - Shadeland Ave.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.